ASND - Ascendis Pharma AS - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ASND is currently covered by 14 analysts with an average price target of $299.41. This is a potential upside of $69.36 (30.15%) from yesterday's end of day stock price of $230.05.

Ascendis Pharma AS's activity chart (see below) currently has 430 price targets and 311 ratings on display. The stock rating distribution of ASND is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.52% with an average time for these price targets to be met of 480.2 days.

Highest price target for ASND is $355, Lowest price target is $254, average price target is $299.41.

Most recent stock forecast was given by MARTIN AUSTER from RAYMOND JAMES on 15-Sep-2026. First documented stock forecast 23-Feb-2015.

Currently out of the existing stock ratings of ASND, 39 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Oct-2025

$287

$61.4 (27.22%)

$271

14 days ago
(15-Sep-2026)

2/3 (66.67%)

$47.23 (19.70%)

246

Buy Since 20-Mar-2020

$312

$86.4 (38.30%)

$262

27 days ago
(02-Sep-2026)

14/15 (93.33%)

$44.69 (16.72%)

921

Buy Since 02-Jul-2025

$273

$47.4 (21.01%)

$275

28 days ago
(01-Sep-2026)

2/4 (50%)

$12.75 (4.90%)

321

Buy Since 02-May-2025

$327

$101.4 (44.95%)

$273

28 days ago
(01-Sep-2026)

4/5 (80%)

$66.75 (25.65%)

102

Buy Since 27-Aug-2026

$344

$118.4 (52.48%)

$345

29 days ago
(31-Aug-2026)

0/2 (0%)

$80.96 (30.78%)

Show more analysts

Please expand the browser size to see the chart

What is ASND (Ascendis Pharma AS) average time for price targets to be met?

On average it took 480 days for the stock forecasts to be reached, with an average price target met ratio of 83.52%.

Which analyst most recently updated their price target on ASND (Ascendis Pharma AS)?

Martin Auster

Which analyst has the most public recommendations on ASND (Ascendis Pharma AS)?

Martin Auster works at RAYMOND JAMES and has 22 price targets and 14 ratings on ASND

Which analyst is the currently most bullish on ASND (Ascendis Pharma AS)?

Mitchell Kapoor with the highest potential upside of $118.4

Which analyst is the currently most reserved on ASND (Ascendis Pharma AS)?

Tiago Fauth with the lowest potential downside of -$136.6
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?